Uterine sarcomas: a 10-year experience and a review of the literature

By Yildirim Yusuf   İnal M. Murat   Sanci Muzaffer   Şentaş Abdulmuttalip   Hanhan Merih  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 7-12

Informa Healthcare

Access to resources Recommend Favorite

Prognostic factors in soft tissue sarcomas: The Aarhus experience

By Vraa S.   Keller J.   Nielsen O.S.   Sneppen O.   Jurik A.G.   Jensen O.M.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1876-1882

Elsevier

Access to resources Recommend Favorite

PTEN Mutations in Uterine Sarcomas

By Amant F.   de la Rey M.   Dorfling C.M.   van der Walt L.   Dreyer G.   Dreyer L.   Vergote I.   Lindeque B.G.   Van Rensburg E.J.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 165-169

Elsevier

Access to resources Recommend Favorite

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group

By Pautier P.   Floquet A.   Gladieff L.   Bompas E.   Ray-Coquard I.   Piperno-Neumann S.   Selle F.   Guillemet C.   Weber B.   Largillier R.   Bertucci F.   Opinel P.   Duffaud F.   Reynaud-Bougnoux A.   Delcambre C.   Isambert N.   Kerbrat P.   Netter-Pinon G.   Pinto N.   Duvillard P.   Haie-Meder C.   Lhomm C.   Rey A.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1099-1104

Oxford University Press

Access to resources Recommend Favorite

Treating soft tissue sarcomas with adjuvant chemotherapy

By Patrikidou Anna  

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 21-31

Springer Publishing Company

Access to resources Recommend Favorite